Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Additional univariate analysis comparing T-score ranges demonstrated that among patients with urolithiasis, those who had low T-scores were older and had lower BMI, higher prevalence of pseudohypoparathyroidism and renal tubular acidosis, higher bisphosphonate and thiazide use, and a lower and higher probability of having hyperphosphaturia and hypocitraturia, respectively (Table 3).Association between bone mineral density, disease severity, and osteogenesis parameters in patients with urolithiasisT-scorep value> − 1.0 (n = 186)− 1 to − 2.5 (n = 135)< − 2.5 (n = 49)Age (years)55.3 ± 14.657.8 ± 14.664.9 ± 12.4< 0.001BMI (kg/m2)25.8 ± 5.123.5 ± 4.521.6 ± 2.5< 0.001Age of onset (years)44.9 ± 16.046.1 ± 17.154.3 ± 17.30.01Recurrence89 (54.3)65 (56.0)20 (45.5)0.48Previous history of urolithiasis113 (63.8)69 (56.1)34 (70.8)0.16Presence of symptoms during clinic visits9.3 ± 0.49.3 ± 0.49.3 ± 0.50.39Family history of stones13 (19.4)12 (32.4)1 (7.7)0.13DM24 (13.3)19 (15.0)7 (14.9)0.91HLP51 (28.5)32 (25.2)11 (23.4)0.70HTN56 (31.1)36 (28.3)17 (35.4)0.66PHP2 (1.2)4 (3.2)5 (11.1)0.004RTA1 (0.6)0 (0.0)2 (4.4)0.02Fluid recommendation149 (82.3)105 (82.7)41 (85.4)0.54Nutrition recommendation169 (93.4)119 (93.7)44 (91.7)0.66Bisphosphonate use1 (0.5)6 (4.4)15 (30.6)< 0.001NaKCit use37 (20.7)31 (24.4)12 (26.1)0.63Thiazide use0 (0.0)0 (0.0)1 (2.2)0.04VitD supplementation2 (1.2)0 (0.0)2 (4.3)0.07Serum Ca (mg/dL)9.3 ± 0.49.3 ± 0.49.3 ± 0.50.39Serum P (mg/dL)3.2 ± 0.53.2 ± 0.63.4 ± 0.40.33Serum PTH (mg/dL)44.5 ± 21.447.2 ± 23.856.4 ± 26.30.21Urinary pH6.50 [6.00, 7.00]6.58 [6.00, 7.00]6.75 [6.12, 7.00]0.47Urinary volume (L/day)1.50 [1.03, 2.15]1.40 [1.10, 1.95]1.40 [1.13, 1.88]0.72Hypercalciuria13 (7.0)17 (12.6)2 (4.1)0.10Hyperphosphaturia23 (12.4)12 (8.9)0 (0.0)0.03Hyperoxaluria56 (30.1)32 (23.7)10 (20.4)0.26Hypocitraturia92 (49.5)76 (56.3)35 (71.4)0.02Values are presented as means ± SD, n (%), or medians [interquartile range]Definitions of urine abnormalities: hypercalciuria ≥ 300 mg/day; hyperphosphaturia ≥ 3 g/day; hypernatriuria ≥ 5.8 g/day; hyperoxaluria ≥ 40 mg/day; hypocitraturia ≤ 320 mg/dayBMI, body mass index; DM, diabetes mellitus, HLP, hyperlipidemia; HTN, hypertension, PHP, pseudohypoparathyroidism; RTA, renal tubular acidosis; VitD, vitamin D; SD, standard deviation, Ca, calcium, P, phosphorus, PTH, parathyroid hormone

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study

Source: Article title.

A total of 370 patients were included in this 10-year study period.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study

Cohort study · BMC Urology · 2020

Original publication title

Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study

Kazumi Taguchi; Shuzo Hamamoto; Atsushi Okada; Yutaro Tanaka; Teruaki Sugino; Rei Unno; Taiki Kato; Ryosuke Ando; Keiichi Tozawa; Takahiro Yasui

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These results revealed that low T-scores might cause symptoms in patients with urolithiasis, suggesting the importance of BMD examination for high-risk Japanese patients with urolithiasis having hypocitraturia.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Patients with urolithiasis have a lower bone mineral density (BMD) than those without stones, suggesting a potential correlation between calcium stone formation and bone resorption disorders, including osteopenia and osteoporosis.

Source: Background

Abstract: What methods does the paper describe?

To investigate the influence of BMD on clinical outcomes in urolithiasis, we performed a single-center retrospective cohort study to analyze patients with urolithiasis who underwent both BMD examination and 24-h urine collection between 2006 and 2015. Data from the national cross-sectional surveillance of the Japanese Society on Urolithiasis Research in 2015 were utilized, and additional data related to urinary tract stones were obtained from medical records. The primary outcome was the development of stone-related symptoms and recurrences during follow-up. A total of 370 patients were included in this 10-year study period.

Source: Methods

Abstract: Results

Half of the patients had recurrent stones, and the two-thirds were symptomatic stone formers. While only 9% of patients had hypercalciuria, 27% and 55% had hyperoxaluria and hypocitraturia, respectively. There was a positive correlation between T-scores and urinary citrate excretion. Both univariate and multivariate analyses demonstrated that female sex was associated with recurrences (odds ratio = 0.44, p = 0.007), whereas a T-score < − 2.5 and hyperoxaluria were associated with symptoms (odds ratio = 2.59, p = 0.037; odds ratio = 0.45, p = 0.01; respectively).

Source: Results

Abstract: Conclusion

These results revealed that low T-scores might cause symptoms in patients with urolithiasis, suggesting the importance of BMD examination for high-risk Japanese patients with urolithiasis having hypocitraturia.

Source: Conclusion
Authors’ abstract

Background

Patients with urolithiasis have a lower bone mineral density (BMD) than those without stones, suggesting a potential correlation between calcium stone formation and bone resorption disorders, including osteopenia and osteoporosis.

Methods

To investigate the influence of BMD on clinical outcomes in urolithiasis, we performed a single-center retrospective cohort study to analyze patients with urolithiasis who underwent both BMD examination and 24-h urine collection between 2006 and 2015. Data from the national cross-sectional surveillance of the Japanese Society on Urolithiasis Research in 2015 were utilized, and additional data related to urinary tract stones were obtained from medical records. The primary outcome was the development of stone-related symptoms and recurrences during follow-up. A total of 370 patients were included in this 10-year study period.

Results

Half of the patients had recurrent stones, and the two-thirds were symptomatic stone formers. While only 9% of patients had hypercalciuria, 27% and 55% had hyperoxaluria and hypocitraturia, respectively. There was a positive correlation between T-scores and urinary citrate excretion. Both univariate and multivariate analyses demonstrated that female sex was associated with recurrences (odds ratio = 0.44, p = 0.007), whereas a T-score < − 2.5 and hyperoxaluria were associated with symptoms (odds ratio = 2.59, p = 0.037; odds ratio = 0.45, p = 0.01; respectively).

Conclusion

These results revealed that low T-scores might cause symptoms in patients with urolithiasis, suggesting the importance of BMD examination for high-risk Japanese patients with urolithiasis having hypocitraturia.

Publication and source details

Original title: Low bone mineral density is a potential risk factor for symptom onset and related with hypocitraturia in urolithiasis patients: a single-center retrospective cohort study

Kazumi Taguchi; Shuzo Hamamoto; Atsushi Okada; Yutaro Tanaka; Teruaki Sugino; Rei Unno; Taiki Kato; Ryosuke Ando; Keiichi Tozawa; Takahiro Yasui

BMC Urology · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.http://dx.doi.org/10.13039/501100001691Japan Society for the Promotion of Science16K11054, 16K15692, 17K11188, 18K09201, 18K09173, 18K09174, and 18K09143Yasui Takahiro http://dx.doi.org/10.13039/100007449Takeda Science Foundationmedical research grantTaguchi Kazumi

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T14:18:19.868717+00:00

DOI: 10.1186/s12894-020-00749-5 · PMC7596945